Hepatitis C virus protease inhibitor-resistance mutations: Our experience and review

doi:10.3748/wjg.v19.i47.8940

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 47

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (8421)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-4) series.

Item

Count

PDF

587

HTML

5182

Figures (1-1)

309

Tables (1-4)

279

Sum=6357

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1001

Download

1063

Sum=2064

Dec 21, 2013 (publication date) through Feb 8, 2025

Times Cited of This Article

Times Cited (30)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Dec 21, 2013; 19(47): 8940-8948
Published online Dec 21, 2013. doi: 10.3748/wjg.v19.i47.8940

Table 2 Clinical characteristics of hepatitis C virus genotype 1b-infected patients in sequence analysis study of the hepatitis C virus NS3 region

No. of patients (men/women)	88 (43/45)
Age (yr)	55 ± 14
HCV RNA levels (low/high)	1/87
ALT (IU/L)	67 ± 44
WBC (x 10³/mcL)	5.2 ± 1.5
Hemoglobin (g/dL)	14 ± 1.2
Platelet counts (x 10⁴/mcL)	20 ± 18
IL28B rs8099917, TT/TG/GG/unknown	45/29/0/14

HCV RNA levels, low: less than 5 log IU/mL; HCV RNA levels, high: equal to or more than 5 log IU/mL; ALT: Alanine aminotransferase; HCV: Hepatitis C virus; WBC: White blood cell.

Citation: Wu S, Kanda T, Nakamoto S, Imazeki F, Yokosuka O. Hepatitis C virus protease inhibitor-resistance mutations: Our experience and review. World J Gastroenterol 2013; 19(47): 8940-8948
URL: https://www.wjgnet.com/1007-9327/full/v19/i47/8940.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i47.8940